Trial Profile
A Post-marketing Surveillance Study Evaluating the Safety and Tolerability of the Labeled Use of Hetero-Darbepoetin Alfa in Indian Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Sponsors Hetero Drugs
- 04 May 2017 New trial record